Hip-Fracture Delirium Cohort Used Midazolam Within a Shared Anesthetic Regimen

A drug given within a common protocol cannot be evaluated as though it were the randomized comparison.

What the supplied source reports

The prospective cohort included 572 older hip-fracture patients undergoing arthroplasty; 120 developed postoperative delirium. The anesthesia methods included midazolam among several agents. The analysis identified associations with age, stroke history, laboratory values, operation duration and transfusion volume.

Limits of the evidence

The study did not randomize midazolam exposure against a benzodiazepine-free regimen. Its risk-factor model therefore cannot establish the benefit or harm of omitting that drug. Even an adjusted predictor does not prove that correcting it will prevent delirium.

Implications for expert analysis

When citing this cohort, describe the actual comparison and shared care. Do not label every delirium episode benzodiazepine-induced merely because midazolam appeared in induction. The study supports a multifactorial assessment that includes baseline disease, surgery, blood loss and physiological stress.

Source and related reading

Source: Publication PMC5580064, read from the supplied PDF. Applications to expert analysis are interpretation.